All Insights
Regulatory & Compliance 1/29/2026 Dr. Farhana Sultana
WHO-GMP Audits: Preparing Your Bangladesh Facility for 2026 Inspections
Documentation systems, deviation trends, and data integrity — what DGDA and international auditors focus on during GMP inspections.
DGDA has increased the frequency of WHO-GMP inspections for local manufacturers and MAH partners. The 2026 inspection cycle emphasizes data integrity, computerized system validation, and supply-chain traceability.
Inventa supports partner facilities with mock audits, SOP gap analysis, and remediation project management. Our quality team has guided 12 successful inspections in the past 24 months.
Top findings to address proactively
- Incomplete batch record review signatures
- Environmental monitoring excursions without documented investigation
- Supplier qualification files missing periodic re-evaluation
- Training records not aligned to role-specific curricula
WHO-GMPAuditQualityPharma